Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
today announced that updated preclinical data for its continuous blood glucose monitor (“CBGM”) will be presented at the 24th An Biotech veteran joins Glucotrack’s Board to support bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback